HIV prevention trial design in an era of effective pre-exposure prophylaxis.

Files

Cutrell Amy_2017.pdf (709.76 KB)

Date

Authors

Donnell, Deborah.

Glidden, David V.

Grobler, Anna Christina.

Hanscom, Brett.

Stancil, Britt S.

Meyer, Daniel R.

Cuffe, Robert L.

Publisher

American Association for the Advancement of Science.

Abstract

Abstract available in pdf.

Description

CAPRISA, 2017.

Keywords

HIV-1., Pre-exposure prophylaxis (PrEP), TDF/FTC., Non-inferiority trials., Tenofovir disoproxil fumarate/emtricitabine.

Citation

Cutrell, A., Donnell, D., Dunn, D.T., Glidden, D.V., Grobler, A., Hanscom, B., Stancil, B.S., Meyer, R.D., Wang, R. and Cuffe, R.L. 2017. HIV prevention trial design in an era of effective pre-exposure prophylaxis. HIV clinical trials 18(5-6), 177-188.

URI

http://hdl.handle.net/10413/15098

Collections

Research papers (Caprisa)